| ALGBE Stock | | | EUR 0.78 0.04 4.88% |
President
Dr. Philippe Marliere was Director of Global Bioenergies SA since February 13, 2009. He is the cofounder of the Company. A graduate of Ecole Normale Superieure, he has focused on the launch of the field of synthetic biology during his academic career. He has since pursued his scientific work in several biotechnology companies that he has founded or cofounded. As a scientific partner of the CEA he advises the Director of Life Sciences in the fields of bioenergy and synthetic biology. Dr. Marliere currently serves as Chairman of Heurisko Inc and Director of Scientist of Fortune and of Enuma Holding. During the last five years, he has also served as President of Societe Marliere Technologies. since 2009.
| Age | 66 |
| Tenure | 15 years |
| Phone | 33 1 64 98 20 50 |
| Web | https://www.global-bioenergies.com |
Glob Bioenergi Management Efficiency
The company has return on total asset
(ROA) of
(0.309) % which means that it has lost $0.309 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(1.1302) %, meaning that it generated substantial loss on money invested by shareholders. Glob Bioenergi's management efficiency ratios could be used to measure how well Glob Bioenergi manages its routine affairs as well as how well it operates its assets and liabilities.
Glob Bioenergi has accumulated 5.13
M in total debt with debt to equity ratio
(D/E) of 145.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Glob Bioenergi has a current ratio of 1.55, which is within standard range for the sector. Debt can assist Glob Bioenergi until it has trouble settling it off, either with new capital or with free cash flow. So, Glob Bioenergi's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Glob Bioenergi sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Glob to invest in growth at high rates of return. When we think about Glob Bioenergi's use of debt, we should always consider it together with cash and equity.
Global Bioenergies SA focuses on the development of a biological process for converting renewable resources into isobutene. Global Bioenergies SA was founded in 2008 and is headquartered in Evry, France. GLOBAL BIOENERGIES operates under Utilities - Diversified classification in France and is traded on Paris Stock Exchange. It employs 54 people. Glob Bioenergi (ALGBE) is traded on Euronext Paris in France and employs 48 people.
Management Performance
Glob Bioenergi Leadership Team
Elected by the shareholders, the Glob Bioenergi's board of directors comprises two types of representatives: Glob Bioenergi inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Glob. The board's role is to monitor Glob Bioenergi's management team and ensure that shareholders' interests are well served. Glob Bioenergi's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Glob Bioenergi's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Frdric Ollivier, Chief Officer | |
| Florence Thueux, Chief Officer | |
| Philippe Marliere, Co-Founder and President of Scientific Advisory Board and Director | |
| Romain Chayot, Head Department | |
| Marc Delcourt, Co-Founder, CEO, Chairman of Strategy Committee and Member of Coordination Committee | |
| Sabine Mazaleyrat, Head Optimization | |
| Claudia Erning, Vice President of Investor Relations | |
| Samuel Dubruque, Chief Financial and Administrative Officer | |
| Denis Thibaut, Head Department | |
| Alexandra Moncada, Chief Officer | |
Glob Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Glob Bioenergi a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Glob Stock Analysis
When running Glob Bioenergi's price analysis, check to
measure Glob Bioenergi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glob Bioenergi is operating at the current time. Most of Glob Bioenergi's value examination focuses on studying past and present price action to
predict the probability of Glob Bioenergi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Glob Bioenergi's price. Additionally, you may evaluate how the addition of Glob Bioenergi to your portfolios can decrease your overall portfolio volatility.